Carillon Tower Advisers’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-720,855
Closed -$26.9M 481
2020
Q1
$26.9M Hold
720,855
0.26% 133
2019
Q4
$40.8M Hold
720,855
0.27% 133
2019
Q3
$38.4M Hold
720,855
0.27% 134
2019
Q2
$42.1M Buy
+720,855
New +$38.7M 0.29% 121
2018
Q2
Sell
-71,649
Closed -$3.51M 510
2018
Q1
$3.51M Hold
71,649
0.03% 397
2017
Q4
$4.72K Buy
+71,649
New +$4.56M 0.05% 228

Other funds holding XRAY

Carillon Tower Advisers's XRAY Position: Q2 2020 in Review

Carillon Tower Advisers sold out of Dentsply Sirona (XRAY) in Q2 2020, closing a stake of 720,855 shares — an estimated $26.9M sold.

Carillon Tower Advisers first reported a position in XRAY in Q4 2017 and held it in 6 quarters. The position peaked at $42.1M in Q2 2019. 504 funds tracked by Wall St. Rank hold XRAY as of Q2 2020.

  • Carillon Tower Advisers reported no remaining Dentsply Sirona position as of Q2 2020 after selling out during the quarter.
  • Carillon Tower Advisers sold 720,855 Dentsply Sirona shares in Q2 2020, an estimated $26.9M.
  • Carillon Tower Advisers first reported a position in Dentsply Sirona in Q4 2017 and held it in 6 quarters.
  • Carillon Tower Advisers's Dentsply Sirona position peaked at $42.1M in Q2 2019.
  • 504 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2020.

Based on Carillon Tower Advisers's 13F filing for Q2 2020, filed 12 Aug 2020.